# The Role of IMP3 Expression in Patients With Neuroblastoma

> **NCT01121419** · — · COMPLETED · sponsor: **National Taiwan University Hospital**

## Conditions studied

- Neuroblastoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01121419
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** — (—)
- **Last updated:** 2010-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01121419

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01121419, "The Role of IMP3 Expression in Patients With Neuroblastoma". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01121419. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*